Pharmaceutical Grade Lactose Market Research Report: Information By Type (Crystalline Monohydrate Lactose, Inhalation Lactose, Granulated Lactose, and Spray Dried Lactose), By Application (Tablets Manufacturing, and Capsule Manufacturing) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

1 EXECUTIVE SUMMARY

1.1 OVERVIEW 16

1.1.1 MARKET SYNOPSIS 16

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY 17

2.2 RESEARCH OBJECTIVE 17

2.3 LIST OF ASSUMPTIONS 17

3 RESEARCH METHODOLOGY

3.1 OVERVIEW 19

3.2 DATA MINING 19

3.3 SECONDARY RESEARCH 19

3.4 PRIMARY RESEARCH 20

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 21

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 21

3.5 FORECASTING TECHNIQUES 22

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 23

3.6.1 BOTTOM-UP APPROACH 23

3.6.2 TOP-DOWN APPROACH 24

3.7 DATA TRIANGULATION 24

3.8 VALIDATION 24

4 MARKET DYNAMICS

4.1 OVERVIEW 25

4.2 DRIVERS 26

4.2.1 INCREASING DEMAND FOR DRY POWDER INHALER (DPI) PRODUCTS 26

4.2.2 COMPATIBILITY WITH ACTIVE PHARMACEUTICAL INGREDIENTS AND OTHER EXCIPIENTS 26

4.2.3 RISING RESEARCH AND DEVELOPMENT IN THE PHARMACEUTICAL INDUSTRY 26

4.3 RESTRAINTS 27

4.3.1 LACTOSE INDUCED PROBLEMS 27

4.3.2 STRINGENT GOVERNMENT REGULATIONS 27

4.3.3 LACK OF COMPATIBILITY WITH AMINE-BASED DRUGS 28

4.4 OPPORTUNITIES 28

4.4.1 DRUG FORMULATION WITH NANOTECHNOLOGY WILL BOOST THE GROWTH OF THE PHARMACEUTICAL GRADE LACTOSE MARKET 28

5 MARKET FACTOR ANALYSIS

5.1 PORTER’S FIVE FORCES MODEL 29

5.1.1 THREAT OF NEW ENTRANTS 30

5.1.2 BARGAINING POWER OF SUPPLIERS 30

5.1.3 THREAT OF SUBSTITUTES 30

5.1.4 BARGAINING POWER OF BUYERS 30

5.1.5 INTENSITY OF RIVALRY 30

5.2 VALUE CHAIN ANALYSIS 31

5.2.1 R&D 32

5.2.2 MANUFACTURING 32

5.2.3 DISTRIBUTION & SALES 32

5.2.4 POST-SALES MONITORING 32

5.3 IMPACT OF COVID-19 ON PHARMACEUTICAL GRADE LACTOSE MARKET 33

5.3.1 OVERVIEW 33

5.3.2 IMPACT ON SUPPLY CHAIN 33

5.3.3 IMPACT ON PRODUCTION 34

6 GLOBAL PHARMACEUTICAL GRADE LACTOSE MARKET, BY TYPE

6.1 OVERVIEW 35

6.2 CRYSTALLINE MONOHYDRATE LACTOSE 36

6.3 INHALATION LACTOSE 37

6.4 GRANULATED LACTOSE 38

6.5 SPRAY DRIED LACTOSE 39

7 GLOBAL PHARMACEUTICAL GRADE LACTOSE MARKET, BY APPLICATION

7.1 INTRODUCTION 41

7.2 TABLETS MANUFACTURING 42

7.3 CAPSULE MANUFACTURING 43

8 GLOBAL PHARMACEUTICAL GRADE LACTOSE MARKET, BY REGION

8.1 INTRODUCTION 45

8.2 EUROPE 46

8.2.1 WESTERN EUROPE 49

8.2.1.1 GERMANY 53

8.2.1.2 FRANCE 56

8.2.1.3 UK 58

8.2.1.4 ITALY 61

8.2.1.5 SPAIN 64

8.2.1.6 REST OF WESTERN EUROPE 67

8.2.2 EASTERN EUROPE 70

8.3 ASIA-PACIFIC 73

8.3.1 CHINA 77

8.3.2 JAPAN 79

8.3.3 INDIA 82

8.3.4 SOUTH KOREA 85

8.3.5 AUSTRALIA 88

8.3.6 REST OF ASIA-PACIFIC 91

8.4 AMERICAS 94

8.4.1 NORTH AMERICA 97

8.4.1.1 US 101

8.4.1.2 CANADA 104

8.4.2 SOUTH AMERICA 107

8.5 MIDDLE EAST & AFRICA 110

8.5.1 MIDDLE EAST 113

8.5.2 AFRICA 116

9 COMPETITIVE LANDSCAPE

9.1 OVERVIEW 119

9.2 COMPETITIVE BENCHMARKING 120

9.3 GLOBAL PHARMACEUTICAL GRADE LACTOSE MARKET: COMPANY RANK ANALYSIS 120

9.4 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 121

9.5 MAJOR GROWTH STRATEGY IN THE GLOBAL PHARMACEUTICAL GRADE LACTOSE MARKET 121

9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 121

9.6.1 PRODUCT APPROVALS 121

9.6.2 ACQUISITIONS 122

9.6.3 EXPANSIONS 122

9.7 FINANCIAL MATRIX 122

10 COMPANY PROFILES

10.1 KERRY INC. 124

10.1.1 COMPANY OVERVIEW 124

10.1.2 FINANCIAL OVERVIEW 124

10.1.3 PRODUCTS/SERVICES OFFERED 125

10.1.4 KEY DEVELOPMENTS 125

10.1.5 SWOT ANALYSIS 126

10.1.6 KEY STRATEGIES 126

10.2 DFE PHARMA 127

10.2.1 COMPANY OVERVIEW 127

10.2.2 FINANCIAL OVERVIEW 127

10.2.3 PRODUCTS/SERVICES OFFERED 127

10.2.4 KEY DEVELOPMENTS 128

10.2.5 SWOT ANALYSIS 128

10.2.6 KEY STRATEGIES 129

10.3 MEGGLE EXCIPIENTS & TECHNOLOGY 130

10.3.1 COMPANY OVERVIEW 130

10.3.2 FINANCIAL OVERVIEW 130

10.3.3 PRODUCTS OFFERED 130

10.3.4 KEY DEVELOPMENTS 130

10.3.5 SWOT ANALYSIS 131

10.3.6 KEY STRATEGIES 131

10.4 MERCK KGAA 132

10.4.1 COMPANY OVERVIEW 132

10.4.2 FINANCIAL OVERVIEW 132

10.4.3 PRODUCTS/SERVICES OFFERED 133

10.4.4 KEY DEVELOPMENTS 133

10.4.5 SWOT ANALYSIS 134

10.4.6 KEY STRATEGIES 134

10.5 ARMOR PHARMA 135

10.5.1 COMPANY OVERVIEW 135

10.5.2 FINANCIAL OVERVIEW 135

10.5.3 PRODUCTS/SERVICES OFFERED 135

10.5.4 KEY DEVELOPMENTS 135

10.5.5 SWOT ANALYSIS 136

10.5.6 KEY STRATEGIES 136

10.6 ALPAVIT 137

10.6.1 COMPANY OVERVIEW 137

10.6.2 FINANCIAL OVERVIEW 137

10.6.3 PRODUCTS/SERVICES OFFERED 137

10.6.4 KEY DEVELOPMENTS 137

10.6.5 SWOT ANALYSIS 138

10.6.6 KEY STRATEGIES 138

10.7 BASF SE 139

10.7.1 COMPANY OVERVIEW 139

10.7.2 FINANCIAL OVERVIEW 139

10.7.3 PRODUCTS OFFERED 140

10.7.4 KEY DEVELOPMENTS 140

10.7.5 SWOT ANALYSIS 140

10.7.6 KEY STRATEGIES 140

11 APPENDIX

11.1 REFERENCES 141

11.2 RELATED REPORTS 141

12 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 17

TABLE 2 GLOBAL PHARMACEUTICAL GRADE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 36

TABLE 3 GLOBAL CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY REGION, 2020–2027 (USD MILLION) 36

TABLE 4 GLOBAL CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 37

TABLE 5 GLOBAL Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 37

TABLE 6 GLOBAL INHALATION LACTOSE MARKET, BY REGION, 2020–2027 (USD MILLION) 38

TABLE 7 GLOBAL INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 38

TABLE 8 GLOBAL GRANULATED LACTOSE MARKET, BY REGION, 2020–2027 (USD MILLION) 39

TABLE 9 GLOBAL SPRAY DRIED LACTOSE MARKET, BY REGION, 2020–2027 (USD MILLION) 40

TABLE 10 GLOBAL PHARMACEUTICAL GRADE LACTOSE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 42

TABLE 11 GLOBAL PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY REGION 2020–2027 (USD MILLION) 42

TABLE 12 GLOBAL PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 43

TABLE 13 GLOBAL PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY REGION 2020–2027 (USD MILLION) 43

TABLE 14 GLOBAL PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 44

TABLE 15 GLOBAL PHARMACEUTICAL GRADE LACTOSE MARKET, BY REGION, 2020–2027 (USD MILLION) 45

TABLE 16 EUROPE PHARMACEUTICAL GRADE LACTOSE MARKET BY REGION, 2020–2027 (USD MILLION) 46

TABLE 17 EUROPE PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020–2027 (USD MILLION) 47

TABLE 18 EUROPE CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 47

TABLE 19 EUROPE Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 47

TABLE 20 EUROPE INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 48

TABLE 21 EUROPE PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 (USD MILLION) 48

TABLE 22 EUROPE PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 48

TABLE 23 EUROPE PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 49

TABLE 24 WESTERN EUROPE PHARMACEUTICAL GRADE LACTOSE MARKET BY COUNTRY, 2020–2027 (USD MILLION) 50

TABLE 25 WESTERN EUROPE PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020–2027 (USD MILLION) 50

TABLE 26 WESTERN EUROPE CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 51

TABLE 27 WESTERN EUROPE Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 51

TABLE 28 WESTERN EUROPE INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 51

TABLE 29 WESTERN EUROPE PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 (USD MILLION) 52

TABLE 30 WESTERN EUROPE PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 52

TABLE 31 WESTERN EUROPE PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 52

TABLE 32 GERMANY PHARMACEUTICAL GRADE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 53

TABLE 33 GERMANY CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 53

TABLE 34 GERMANY Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 54

TABLE 35 GERMANY INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 54

TABLE 36 GERMANY PHARMACEUTICAL GRADE LACTOSE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 54

TABLE 37 GERMANY PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 55

TABLE 38 GERMANY PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 55

TABLE 39 FRANCE PHARMACEUTICAL GRADE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 56

TABLE 40 FRANCE CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 56

TABLE 41 FRANCE Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 56

TABLE 42 FRANCE INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 57

TABLE 43 FRANCE PHARMACEUTICAL GRADE LACTOSE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 57

TABLE 44 FRANCE PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 57

TABLE 45 FRANCE PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 58

TABLE 46 UK PHARMACEUTICAL GRADE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 58

TABLE 47 UK CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 59

TABLE 48 UK Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 59

TABLE 49 UK INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 59

TABLE 50 UK PHARMACEUTICAL GRADE LACTOSE MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 60

TABLE 51 UK PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 60

TABLE 52 UK PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 60

TABLE 53 ITALY PHARMACEUTICAL GRADE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 61

TABLE 54 ITALY CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 61

TABLE 55 ITALY Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 62

TABLE 56 ITALY INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 62

TABLE 57 ITALY PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 (USD MILLION) 62

TABLE 58 ITALY PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 63

TABLE 59 ITALY PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 63

TABLE 60 SPAIN PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020–2027 (USD MILLION) 64

TABLE 61 SPAIN CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 64

TABLE 62 SPAIN Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 64

TABLE 63 SPAIN INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 65

TABLE 64 SPAIN PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 (USD MILLION) 65

TABLE 65 SPAIN PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 66

TABLE 66 SPAIN PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 66

TABLE 67 REST OF WESTERN EUROPE PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020–2027 (USD MILLION) 67

TABLE 68 REST OF WESTERN EUROPE CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 67

TABLE 69 REST OF WESTERN EUROPE Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 67

TABLE 70 REST OF WESTERN EUROPE INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 68

TABLE 71 REST OF WESTERN EUROPE PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 (USD MILLION) 68

TABLE 72 REST OF WESTERN EUROPE PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 69

TABLE 73 REST OF WESTERN EUROPE PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 69

TABLE 74 EASTERN EUROPE PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 75 EASTERN EUROPE CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 76 EASTERN EUROPE Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 77 EASTERN EUROPE INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 71

TABLE 78 EASTERN EUROPE PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 (USD MILLION) 71

TABLE 79 EASTERN EUROPE PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 72

TABLE 80 EASTERN EUROPE PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 72

TABLE 81 ASIA-PACIFIC PHARMACEUTICAL GRADE LACTOSE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 73

TABLE 82 ASIA-PACIFIC PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020–2027 (USD MILLION) 74

TABLE 83 ASIA-PACIFIC CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 74

TABLE 84 ASIA-PACIFIC Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 75

TABLE 85 ASIA-PACIFIC INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 75

TABLE 86 ASIA-PACIFIC PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 (USD MILLION) 75

TABLE 87 ASIA-PACIFIC PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 76

TABLE 88 ASIA-PACIFIC PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 76

TABLE 89 CHINA PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020–2027 (USD MILLION) 77

TABLE 90 CHINA CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 77

TABLE 91 CHINA Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 77

TABLE 92 CHINA INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 78

TABLE 93 CHINA PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 (USD MILLION) 78

TABLE 94 CHINA PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 78

TABLE 95 CHINA PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 79

TABLE 96 JAPAN PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020–2027 (USD MILLION) 79

TABLE 97 JAPAN CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 80

TABLE 98 JAPAN Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 80

TABLE 99 JAPAN INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 80

TABLE 100 JAPAN PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 (USD MILLION) 81

TABLE 101 JAPAN PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 81

TABLE 102 JAPAN PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 81

TABLE 103 INDIA PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020–2027 (USD MILLION) 82

TABLE 104 INDIA CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 82

TABLE 105 INDIA Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 83

TABLE 106 INDIA INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 83

TABLE 107 INDIA PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 (USD MILLION) 83

TABLE 108 INDIA PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 84

TABLE 109 INDIA PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 84

TABLE 110 SOUTH KOREA PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020–2027 (USD MILLION) 85

TABLE 111 SOUTH KOREA CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 85

TABLE 112 SOUTH KOREA Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 85

TABLE 113 SOUTH KOREA INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 86

TABLE 114 SOUTH KOREA PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 (USD MILLION) 86

TABLE 115 SOUTH KOREA PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 87

TABLE 116 SOUTH KOREA PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 87

TABLE 117 AUSTRALIA PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020–2027 (USD MILLION) 88

TABLE 118 AUSTRALIA CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 88

TABLE 119 AUSTRALIA Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 88

TABLE 120 AUSTRALIA INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 89

TABLE 121 AUSTRALIA PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 (USD MILLION) 89

TABLE 122 AUSTRALIA PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 90

TABLE 123 AUSTRALIA PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 90

TABLE 124 REST OF ASIA-PACIFIC PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020–2027 (USD MILLION) 91

TABLE 125 REST OF ASIA-PACIFIC CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 91

TABLE 126 REST OF ASIA-PACIFIC Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 91

TABLE 127 REST OF ASIA-PACIFIC INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 92

TABLE 128 REST OF ASIA-PACIFIC PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 (USD MILLION) 92

TABLE 129 REST OF ASIA-PACIFIC PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 93

TABLE 130 REST OF ASIA-PACIFIC PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 93

TABLE 131 AMERICAS PHARMACEUTICAL GRADE LACTOSE MARKET, BY REGION, 2020–2027 (USD MILLION) 94

TABLE 132 AMERICAS PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020–2027 (USD MILLION) 95

TABLE 133 AMERICAS CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 95

TABLE 134 AMERICAS Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 95

TABLE 135 AMERICAS INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 96

TABLE 136 AMERICAS PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 (USD MILLION) 96

TABLE 137 AMERICAS PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 96

TABLE 138 AMERICAS PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 97

TABLE 139 NORTH AMERICA PHARMACEUTICAL GRADE LACTOSE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 98

TABLE 140 NORTH AMERICA PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020–2027 (USD MILLION) 98

TABLE 141 NORTH AMERICA CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 98

TABLE 142 NORTH AMERICA Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 99

TABLE 143 NORTH AMERICA INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 99

TABLE 144 NORTH AMERICA PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 (USD MILLION) 99

TABLE 145 NORTH AMERICA PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 100

TABLE 146 NORTH AMERICA PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 100

TABLE 147 US PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020–2027 (USD MILLION) 101

TABLE 148 US CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 101

TABLE 149 US Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 101

TABLE 150 US INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 102

TABLE 151 US PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 (USD MILLION) 102

TABLE 152 US PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 103

TABLE 153 US PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 103

TABLE 154 CANADA PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020–2027 (USD MILLION) 104

TABLE 155 CANADA CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 104

TABLE 156 CANADA Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 104

TABLE 157 CANADA INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 105

TABLE 158 CANADA PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 (USD MILLION) 105

TABLE 159 CANADA PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 106

TABLE 160 CANADA PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 106

TABLE 161 SOUTH AMERICA PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020–2027 (USD MILLION) 107

TABLE 162 SOUTH AMERICA CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 107

TABLE 163 SOUTH AMERICA Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 107

TABLE 164 SOUTH AMERICA INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 108

TABLE 165 SOUTH AMERICA PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 (USD MILLION) 108

TABLE 166 SOUTH AMERICA PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 108

TABLE 167 SOUTH AMERICA PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 109

TABLE 168 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE LACTOSE MARKET BY REGION, 2020–2027 (USD MILLION) 110

TABLE 169 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020–2027 (USD MILLION) 111

TABLE 170 MIDDLE EAST & AFRICA CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 111

TABLE 171 MIDDLE EAST & AFRICA Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 111

TABLE 172 MIDDLE EAST & AFRICA INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 112

TABLE 173 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 (USD MILLION) 112

TABLE 174 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 112

TABLE 175 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 113

TABLE 176 MIDDLE EAST PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020–2027 (USD MILLION) 113

TABLE 177 MIDDLE EAST CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 114

TABLE 178 MIDDLE EAST Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 114

TABLE 179 MIDDLE EAST INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 114

TABLE 180 MIDDLE EAST PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 (USD MILLION) 115

TABLE 181 MIDDLE EAST PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 115

TABLE 182 MIDDLE EAST PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 115

TABLE 183 AFRICA PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020–2027 (USD MILLION) 116

TABLE 184 AFRICA CRYSTALLINE MONOHYDRATE LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 116

TABLE 185 AFRICA Α-LACTOSE MONOHYDRATE MARKET, BY TYPE, 2020–2027 (USD MILLION) 117

TABLE 186 AFRICA INHALATION LACTOSE MARKET, BY TYPE, 2020–2027 (USD MILLION) 117

TABLE 187 AFRICA PHARMACEUTICAL GRADE LACTOSE MARKET BY APPLICATION, 2020–2027 117

TABLE 188 AFRICA PHARMACEUTICAL GRADE LACTOSE, FOR TABLETS MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 118

TABLE 189 AFRICA PHARMACEUTICAL GRADE LACTOSE MARKET, FOR CAPSULE MANUFACTURING, BY APPLICATION TYPE, 2020–2027 (USD MILLION) 118

TABLE 190 MAJOR MANUFACTURERS COMPANY RANK ANALYSIS, 2020 120

TABLE 191 TOP PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE PHARMACEUTICAL GRADE LACTOSE MARKET 121

TABLE 192 PRODUCT APPROVALS 121

TABLE 193 ACQUISITIONS 122

TABLE 194 EXPANSIONS 122

TABLE 195 KERRY INC.: PRODUCTS/SERVICES OFFERED 125

TABLE 196 KERRY INC.: KEY DEVELOPMENTS 125

TABLE 197 DFE PHARMA: PRODUCTS/SERVICES OFFERED 127

TABLE 198 DFE PHARMA: KEY DEVELOPMENTS 128

TABLE 199 MEGGLE EXCIPIENTS & TECHNOLOGY: PRODUCTS/SERVICES OFFERED 130

TABLE 200 MEGGLE EXCIPIENTS & TECHNOLOGY: KEY DEVELOPMENTS 130

TABLE 201 MERCK KGAA: PRODUCTS/SERVICES OFFERED 133

TABLE 202 MERCK KGAA: KEY DEVELOPMENTS 133

TABLE 203 ARMOR PHARMA: PRODUCTS/SERVICES OFFERED 135

TABLE 204 ALPAVIT: PRODUCTS/SERVICES OFFERED 137

TABLE 205 BASF SE: PRODUCTS OFFERED 140

13 LIST OF FIGURES

FIGURE 1 GLOBAL PHARMACEUTICAL GRADE LACTOSE MARKET STRUCTURE 18

FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 23

FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PHARMACEUTICAL GRADE LACTOSE MARKET 25

FIGURE 4 DRIVERS IMPACT ANALYSIS 27

FIGURE 5 RESTRAINTS IMPACT ANALYSIS 28

FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: GLOBAL PHARMACEUTICAL GRADE LACTOSE MARKET 29

FIGURE 7 VALUE CHAIN ANALYSIS OF THE GLOBAL PHARMACEUTICAL GRADE LACTOSE MARKET 31

FIGURE 8 GLOBAL PHARMACEUTICAL GRADE LACTOSE MARKET BY TYPE, 2020 AND 2027 (USD MILLION) 35

FIGURE 9 GLOBAL PHARMACEUTICAL GRADE LACTOSE MARKET, BY APPLICATION, 2020 AND 2027 (USD MILLION) 41

FIGURE 10 GLOBAL PHARMACEUTICAL GRADE LACTOSE MARKET SHARE, BY REGION, 2020 (%) 45

FIGURE 11 EUROPE PHARMACEUTICAL GRADE LACTOSE MARKET SHARE, BY REGION, 2020 (%) 46

FIGURE 12 WESTERN EUROPE PHARMACEUTICAL GRADE LACTOSE MARKET SHARE, BY COUNTRY, 2020 (%) 49

FIGURE 13 ASIA-PACIFIC PHARMACEUTICAL GRADE LACTOSE MARKET SHARE, BY COUNTRY, 2020 (%) 73

FIGURE 14 AMERICAS PHARMACEUTICAL GRADE LACTOSE MARKET SHARE, BY REGION, 2020 (%) 94

FIGURE 15 NORTH AMERICA PHARMACEUTICAL GRADE LACTOSE MARKET SHARE, BY COUNTRY, 2020 (%) 97

FIGURE 16 MIDDLE EAST & AFRICA PHARMACEUTICAL GRADE LACTOSE MARKET, BY REGION, 2020 (%) 110

FIGURE 17 BENCHMARKING OF MAJOR COMPETITORS 120

FIGURE 18 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL PHARMACEUTICAL GRADE LACTOSE MARKET 121

FIGURE 19 SALES & OPERATING INCOME MARGIN, 2020 122

FIGURE 20 RESEARCH & DEVELOPMENT EXPENDITURE, 2020 123

FIGURE 21 KERRY INC.: FINANCIAL OVERVIEW SNAPSHOT 124

FIGURE 22 KERRY INC.: SWOT ANALYSIS 126

FIGURE 23 DFE PHARMA: SWOT ANALYSIS 128

FIGURE 24 MEGGLE EXCIPIENTS & TECHNOLOGY: SWOT ANALYSIS 131

FIGURE 25 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT 132

FIGURE 26 MERCK KGAA: SWOT ANALYSIS 134

FIGURE 27 ARMOR PHARMA: SWOT ANALYSIS 136

FIGURE 28 ALPAVIT: SWOT ANALYSIS 138

FIGURE 29 BASF SE: FINANCIAL OVERVIEW SNAPSHOT 139

FIGURE 30 BASF SE: SWOT ANALYSIS 140